You are here: Industry Insights > lupin

News List

Lupin gets tentative US FDA nod for generic tablets to treat high BP ExpressPharma
December 28, 2021
Lupin recently said it has received tentative approval from the US health regulator for its generic Azilsartan Medoxomil tablets used to treat high blood pressure.
Lupin recalls 4,113 cartons of oral contraceptive medicine in US market expresspharma
December 13, 2021
The affected lot has been produced at the company’s Pithampur-based manufacturing facility in Madhya Pradesh and distributed in the US by Baltimore-based Lupin Pharmaceuticals...
NPPA fixes retail prices for six formulations expresspharma
August 10, 2021
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices for six formulations under the Drugs (Prices Control) Order, 2013, based on the decision of the authority meeting held on 29th July, 2021.
Lupin’s Generic Health acquires Southern Cross Pharma in Australia expresspharma
August 02, 2021
As a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 million.
Lupin launches Tavaborole Topical Solution in US expresspharma
July 14, 2021
It is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.
Lupin Announces FDA Approval of Supplemental New Drug Application for Solosec (secnidazole) for the Treatment of Trichomoniasis drugs
July 07, 2021
Lupin announced today that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental New Drug Application (sNDA) to expand the use of Solosec (secnidazole) to include the treatment of trichomoniasis in adults.
Lupin gets USFDA approval of sNDA for SOLOSEC (secnidazole) to treat trichomoniasis expresspharma
July 02, 2021
SOLOSEC demonstrated a 92.2 per cent clinically and statistically significant cure rate for patients with trichomoniasis based on a landmark Phase 3 clinical trial.
Lupin gets tentative US FDA nod for Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate (TLD) tablets under PEPFAR expresspharma
July 01, 2021
TLD is recommended by WHO, USAID and PEPFAR as a preferred first-line treatment regimen for the treatment of HIV in adults and pediatric patients weighing at least 35 kg.
Lupin gets US FDA approval for Sevelamer Hydrochloride Tablets expresspharma
June 18, 2021
They are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
Lupin gets warning letter from US FDA for Somerset facility expresspharma
June 16, 2021
The US FDA had inspected the Lupin Somerset site from September 10, 2020, to November 5, 2020.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page